Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol. 2019;20(4):199–210.

CAS  PubMed  Google Scholar 

Lane DP. Cancer p53, guardian of the genome. Nature. 1992;358(6381):15–6.

CAS  PubMed  Google Scholar 

Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979;278(5701):261–3.

CAS  PubMed  Google Scholar 

Linzer DI, Levine AJ. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979;17(1):43–52.

CAS  PubMed  Google Scholar 

Smith AE, Smith R, Paucha E. Characterization of different tumor antigens present in cells transformed by simian virus 40. Cell. 1979;18(2):335–46.

CAS  PubMed  Google Scholar 

Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244(4901):217–21.

CAS  PubMed  Google Scholar 

Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137(4):609–22.

CAS  PubMed  PubMed Central  Google Scholar 

Laptenko O, Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006;13(6):951–61.

CAS  PubMed  Google Scholar 

Farnebo M, Bykov VJ, Wiman KG. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun. 2010;396(1):85–9.

CAS  PubMed  Google Scholar 

Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387(6630):296–9.

CAS  PubMed  Google Scholar 

Momand J, Wu HH, Dasgupta G. MDM2–master regulator of the p53 tumor suppressor protein. Gene. 2000;242(1–2):15–29.

CAS  PubMed  Google Scholar 

Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998;92(6):725–34.

CAS  PubMed  Google Scholar 

Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, et al. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 2004;5(5):465–75.

CAS  PubMed  Google Scholar 

Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell. 2003;112(6):779–91.

CAS  PubMed  Google Scholar 

Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell. 2005;121(7):1071–83.

CAS  PubMed  Google Scholar 

Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 2004;429(6987):86–92.

CAS  PubMed  Google Scholar 

Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS, et al. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci U S A. 2004;101(10):3456–61.

CAS  PubMed  PubMed Central  Google Scholar 

Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408(6810):307–10.

CAS  PubMed  Google Scholar 

Balint EE, Vousden KH. Activation and activities of the p53 tumour suppressor protein. Br J Cancer. 2001;85(12):1813–23.

CAS  PubMed Central  Google Scholar 

Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997;90(4):595–606.

CAS  PubMed  Google Scholar 

Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 2000;406(6792):207–10.

CAS  PubMed  Google Scholar 

Samuels-Lev Y, O’Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001;8(4):781–94.

CAS  PubMed  Google Scholar 

Nikolaev AY, Li M, Puskas N, Qin J, Gu W. Parc: a cytoplasmic anchor for p53. Cell. 2003;112(1):29–40.

CAS  PubMed  Google Scholar 

Huang YF, Wee S, Gunaratne J, Lane DP, Bulavin DV. Isg15 controls p53 stability and functions. Cell Cycle. 2014;13(14):2200–10.

PubMed  Google Scholar 

Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res. 2000;77:81–137.

CAS  PubMed  Google Scholar 

Munoz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri SK, Lee SW, et al. p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol. 2011;187(12):6428–36.

CAS  PubMed  Google Scholar 

Munoz-Fontela C, Macip S, Martinez-Sobrido L, Brown L, Ashour J, Garcia-Sastre A, et al. Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med. 2008;205(8):1929–38.

CAS  PubMed  PubMed Central  Google Scholar 

Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol. 2006;80(17):8582–92.

CAS  PubMed  PubMed Central  Google Scholar 

Lazo PA, Santos CR. Interference with p53 functions in human viral infections, a target for novel antiviral strategies? Rev Med Virol. 2011;21(5):285–300.

CAS  PubMed  Google Scholar 

Li X, Zhang W, Liu Y, Xie J, Hu C, Wang X. Role of p53 in pseudorabies virus replication, pathogenicity, and host immune responses. Vet Res. 2019;50(1):9.

CAS  PubMed  PubMed Central  Google Scholar 

Charni-Natan M, Solomon H, Rotter V. p53 and the viral connection: back into the future (double dagger). Cancers (Basel). 2018;10(6):178.

PubMed  Google Scholar 

Sato Y, Tsurumi T. Genome guardian p53 and viral infections. Rev Med Virol. 2013;23(4):213–20.

CAS  PubMed  Google Scholar 

Maruzuru Y, Fujii H, Oyama M, Kozuka-Hata H, Kato A, Kawaguchi Y. Roles of p53 in herpes simplex virus 1 replication. J Virol. 2013;87(16):9323–32.

CAS  PubMed  PubMed Central  Google Scholar 

Maruzuru Y, Koyanagi N, Takemura N, Uematsu S, Matsubara D, Suzuki Y, et al. p53 is a host cell regulator during herpes simplex encephalitis. J Virol. 2016;90(15):6738–45.

CAS  PubMed  PubMed Central  Google Scholar 

Casavant NC, Luo MH, Rosenke K, Winegardner T, Zurawska A, Fortunato EA. Potential role for p53 in the permissive life cycle of human cytomegalovirus. J Virol. 2006;80(17):8390–401.

CAS  PubMed  PubMed Central  Google Scholar 

Xu D, Du Q, Han C, Wang Z, Zhang X, Wang T, et al. p53 signaling modulation of cell cycle arrest and viral replication in porcine circovirus type 2 infection cells. Vet Res. 2016;47(1):120.

PubMed  PubMed Central  Google Scholar 

Yaseen MM, Yaseen MM, Alqudah MA. Broadly neutralizing antibodies: an approach to control HIV-1 infection. Int Rev Immunol. 2017;36(1):31–40.

CAS  PubMed  Google Scholar 

Alqudah MAY, Yaseen MMM, Yaseen MMS. HIV-1 strategies to overcome the immune system by evading and invading innate immune system. HIV AIDS Rev. 2016;15(1):1–12.

Google Scholar 

Yaseen MM, Abuharfeil NM, Darmani H. Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection. Open Biol. 2021;11(11):210216.

CAS  PubMed  PubMed Central  Google Scholar 

Mohammad Yaseen M, Mohammad Abuharfeil N, Darmani H. T-cell evasion and invasion during HIV-1 infection: the role of HIV-1 Tat protein. Cell Immunol. 2022;377:104554.

CAS  PubMed  Google Scholar 

Yaseen MM, Abuharfeil NM, Homa D. Anatomical distribution of myeloid-derived suppressor cells during HIV infection. Viral Immunol. 2021;10:673–8.

Google Scholar 

Abuharfeil NM, Yaseen MM, Alsheyab FM. Harnessing antibody-dependent cellular cytotoxicity to control HIV-1 infection. ACS Infect Dis. 2019;5(2):158–76.

CAS  PubMed  Google Scholar 

Yaseen MM, Abuharfeil NM, Yaseen MM, Shabsoug BM. The role of polymorphonuclear neutrophils during HIV-1 infection. Arch Virol. 2018;163(1):1–21.

CAS  PubMed  Google Scholar 

Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, et al. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 2001;15(1):5–6.

CAS  PubMed  Google Scholar 

Imbeault M, Ouellet M, Tremblay MJ. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology. 2009;6:5.

PubMed